Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FV6B7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,634
Award facts
- Contract value 100% obligated
- $22,633.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,633.69 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025, issued on November 14, 2025. The pharmaceutical product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting, particularly in post-operative and chemotherapy contexts.
This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill competitive federal requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies supporting military healthcare programs worldwide. The company's federal contract portfolio reflects its critical role in supplying essential medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV6B7?
SPE2DR26FV6B7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FV6B7 worth?
The government has obligated $22,634 on SPE2DR26FV6B7.
Is contract SPE2DR26FV6B7 an order under another contract?
Yes. SPE2DR26FV6B7 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6B7 competed?
The extent of competition for SPE2DR26FV6B7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award